Cite
Supplementary Fig. S2 from Silibinin inhibits translation initiation: implications for anticancer therapy
MLA
Jerry Pelletier, et al. Supplementary Fig. S2 from Silibinin Inhibits Translation Initiation: Implications for Anticancer Therapy. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....20a460c35a2ddd79aa6dcc537f391f20&authtype=sso&custid=ns315887.
APA
Jerry Pelletier, Rami Sukarieh, & Chen-Ju Lin. (2023). Supplementary Fig. S2 from Silibinin inhibits translation initiation: implications for anticancer therapy.
Chicago
Jerry Pelletier, Rami Sukarieh, and Chen-Ju Lin. 2023. “Supplementary Fig. S2 from Silibinin Inhibits Translation Initiation: Implications for Anticancer Therapy,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....20a460c35a2ddd79aa6dcc537f391f20&authtype=sso&custid=ns315887.